US2003087834A1PendingUtilityA1

Increased fertility and improved fetal development drug

Priority: Apr 26, 1999Filed: Nov 20, 2002Published: May 8, 2003
Est. expiryApr 26, 2019(expired)· nominal 20-yr term from priority
A61P 3/04A61K 31/7004C07H 1/00A61P 15/08
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for increasing the fertility of a female mammal comprising administering to said female mammal an efficacious amount of tagatose. A method for promoting healthy fetal development in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose. A method for increasing the birth weight of a fetus in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose. A method for reducing excessive food intake of a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for increasing the fertility of a female mammal comprising administering to said female mammal an efficacious amount of tagatose.  
     
     
         2 . The method of  claim 1  wherein the mammal is a human.  
     
     
         3 . The method of  claim 1  wherein from 100-2000 mg/kg body weight/day is administered to said mammal.  
     
     
         4 . The method of  claim 1  wherein the prescribed dose is taken every day.  
     
     
         5 . The method of  claim 1  wherein the prescribed dose is taken every other day.  
     
     
         6 . The method of  claim 1  wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.  
     
     
         7 . A method for promoting healthy fetal development in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.  
     
     
         8 . The method of  claim 7  wherein the mammal is a human.  
     
     
         9 . The method of  claim 7  wherein from 100-2000 mg/kg body weight/day is administered to said mammal.  
     
     
         10 . The method of  claim 7  wherein the prescribed dose is taken every day.  
     
     
         11 . The method of  claim 7  wherein the prescribed dose is taken every other day.  
     
     
         12 . The method of  claim 1  wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.  
     
     
         13 . A method for increasing the birth weight of a fetus in a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.  
     
     
         14 . The method of  claim 13  wherein the mammal is a human.  
     
     
         15 . The method of  claim 13  wherein from 100-2000 mg/kg body weight/day is administered to said mammal.  
     
     
         16 . The method of  claim 13  wherein the prescribed dose is taken every day.  
     
     
         17 . The method of  claim 13  wherein the prescribed dose is taken every other day.  
     
     
         18 . The method of  claim 13  wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.  
     
     
         19 . A method for reducing excessive food intake of a pregnant female mammal which comprises administering to said mammal an efficacious amount of tagatose.  
     
     
         20 . The method of  claim 19  wherein the mammal is a human.  
     
     
         21 . The method of  claim 19  wherein from 100-2000 mg/kg body weight/day is administered to said mammal.  
     
     
         22 . The method of  claim 19  wherein the prescribed dose is taken every day.  
     
     
         23 . The method of  claim 19  wherein the prescribed dose is taken every other day.  
     
     
         24 . The method of  claim 19  wherein said tagatose is D-tagatose, L-tagatose or a mixture thereof.

Join the waitlist — get patent alerts

Track US2003087834A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.